SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $64,000 | -91.6% | 65 | -91.7% | 0.01% | -90.4% |
Q1 2022 | $766,000 | -96.0% | 784 | -96.0% | 0.05% | -97.7% |
Q2 2021 | $19,107,000 | 0.0% | 19,638 | 0.0% | 2.29% | 0.0% |
Q1 2021 | $19,107,000 | +70.4% | 19,638 | +69.6% | 2.29% | +253.0% |
Q4 2020 | $11,212,000 | -83.0% | 11,578 | -83.7% | 0.65% | -91.1% |
Q3 2020 | $66,106,000 | +12.0% | 71,073 | +7.3% | 7.33% | +3.4% |
Q2 2020 | $59,011,000 | +34.8% | 66,249 | +23.6% | 7.09% | +37.6% |
Q1 2020 | $43,776,000 | -32.7% | 53,600 | -24.8% | 5.15% | -1.3% |
Q4 2019 | $65,085,000 | -11.1% | 71,238 | -9.1% | 5.22% | +9.1% |
Q3 2019 | $73,175,000 | +4.8% | 78,382 | +10.1% | 4.78% | +1.4% |
Q2 2019 | $69,799,000 | – | 71,162 | – | 4.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 71,162 | $69,799,000 | 4.72% |
ZAZOVE ASSOCIATES LLC | 27,692,000 | $27,021,000 | 2.38% |
ADVENT CAPITAL MANAGEMENT /DE/ | 61,727,000 | $60,252,000 | 1.17% |
SHENKMAN CAPITAL MANAGEMENT INC | 7,637,000 | $7,524,000 | 0.85% |
NN Investment Partners Holdings N.V. | 38,700,000 | $37,743,000 | 0.30% |
CAMDEN ASSET MANAGEMENT L P /CA | 5,825,000 | $5,684,000 | 0.18% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 4,479,000 | $4,384,000 | 0.16% |
Lombard Odier Asset Management (Europe) Ltd | 2,005,000 | $1,905,000 | 0.16% |
PRUDENTIAL PLC | 41,809,000 | $40,973,000 | 0.12% |
Calamos Advisors LLC | 22,303,000 | $21,829,000 | 0.12% |